Markqayne Ray, PharmD, MBA

Director - Global HEOR
Kite, a Gilead Company, Santa Monica, CA, USA

Poster(s):

• (309) Systematic Literature Review of Healthcare Resource Use (HCRU), Costs and Health-Related Quality of Life (HRQoL) for Brexucabtagene autoleucel in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) and Precursor B-cell lymphoblastic leukemia (B-ALL)
  Wednesday, October 29, 2025